Company Overview and News

 
Alliance Data Systems' (ADS) CEO Edward Heffernan on Q1 2018 Results - Earnings Call Transcript

52m seekingalpha
Alliance Data Systems Corporation (NYSE:ADS) Q1 2018 Earnings Conference Call April 19, 2018 8:30 AM ET
Upvote Downvote

2
5 Airline Stocks Poised to Beat Earnings Estimates in Q1

2018-04-09 zacks
The current projection for Q1 earnings season is very encouraging. Per the latest earnings preview, the bottom line for S&P 500 companies is expected to expand at a highly impressive rate of 16% on a year-over-year basis. Total revenues for the same set of companies are projected to grow 7.4%. The report further predicts that 14 of the 16 Zacks sectors will end the Q1 earnings season with the bottom line improving year over year.
Upvote Downvote

 
Alaska Air Group Falls to 52-Week Low on Multiple Challenges

2018-04-03 zacks
Shares of Alaska Air Group, Inc. (ALK - Free Report) hit a 52-week low of $57.60 during the trading session on Apr 2 before retracing a bit to close at $57.74. The stock has underperformed its industry in a year, having declined 36% versus the industry’s 13.4% rally.
Upvote Downvote

 
Richard Branson buys Hard Rock casino-hotel in Las Vegas

2018-03-31 livemint
Las Vegas: The Hard Rock Hotel and Casino in Las Vegas will be overhauled over the next several months following its purchase Friday by billionaire Richard Branson.
Upvote Downvote

 
Virgin America departing; Musk unfriends Facebook; name a famous female techie

2018-03-24 sfgate
Virgin America’s final flights will depart at 9:30 p.m. April 24 from San Francisco International Airport — heading to Newark and Los Angeles. As of late Friday morning, the cheapest tickets for the LAX flight cost $63; for the Newark flight, a red-eye, they’re $269, according to Google Flights. The Burlingame airline merged with Alaska Airlines in 2016 and is taking on Alaska’s identity. Alaska is stopping service from SFO to Minneapolis, Fort Lauderdale, Fla.
Upvote Downvote

 
Boeing loyalist Ryanair to fly first Airbus with Austria deal

2018-03-22 reuters
DUBLIN/BERLIN (Reuters) - Ryanair’s (RYA.I) plan to buy Laudamotion will add Airbus (AIR.PA) planes to the Irish low-cost carrier’s fleet for the first time and could herald an improvement in relations with the European planemaker.
Upvote Downvote

 
Boeing loyalist Ryanair to fly first Airbus with Austria deal

2018-03-22 channelnewsasia
Ryanair's plan to buy Laudamotion will add Airbus planes to the Irish low-cost carrier's fleet for the first time and could herald an improvement in relations with the European planemaker.
Upvote Downvote

 
United suspends pet cargo service after in-flight animal deaths double in just one year - MarketWatch

2018-03-20 marketwatch
There was a backlash against the airline after the death of a dog in an overhead bin
Upvote Downvote

 
Alaska Air Group Grapples With Cost Woes: Time to Dump?

2018-03-20 zacks
We have issued an updated research report on Alaska Air Group, Inc. (ALK - Free Report) . The stock has been downgraded to a Zacks Rank #4 (Sell) from a Zacks Rank #3 (Hold). Going by the Zacks proven model, the Sell-rated stocks (#4 or 5) are likely to underperform the broader market over the next one to three months. Reasons Behind the Downgrade High costs have been putting pressure on the company’s bottom line for quite some time, and the fourth quarter of 2017 was no exception.
Upvote Downvote

 
United Airlines had most animal deaths in 2017 — and they doubled in just one year - MarketWatch

2018-03-14 marketwatch
The airline is currently investigating the death of a dog that died in an overhead bin
Upvote Downvote

1
Trapeze Asset Management Q4 2017 Commentary - 'It's Never One Thing'

2018-03-06 seekingalpha
Includes detailed analysis of Trapeze Asset Management's positions in ORXGF, ATXMF, EDYYF, MKRYF, ALK, SBBTF, MDT, TJX, TAP, SIEGY, SNY, JNJ, HHC, HUSKF, CCT, RA, MGRUF, TPRFF.
Upvote Downvote

 
These airlines have the most complaints and lost luggage - MarketWatch

2018-02-26 marketwatch
Consumers can consider many factors when evaluating an airline, but getting you where you’re going on time, not losing your checked bag, and giving you no reason to lodge a formal complaint seem like decent baselines.
Upvote Downvote

 
Why Alaska Air Group's Stock Is Primed To Take Off

2018-02-22 seekingalpha
Analyzing the airline's EV / Free Cash Flow relative to peers highlights how attractive the stock is.
Upvote Downvote

 
Alaska Air Group And Virgin America: What Is It Worth?

2018-02-20 seekingalpha
Using two methods of valuation and 1000 Monte Carlo iterations, my one year target price is $65.93.
Upvote Downvote

 
Southwest Airlines, Strategically Positioned For Long-Term Success

2018-02-16 seekingalpha
Southwest Airlines operates with a low-cost structure and achieves high returns on capital due to a unique business model and an efficient operational strategy.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 92765X208